MRC1 and colorectal carcinoma: In this study we sought to validate the combination of MMR and BRAFV600E IHC as a prognostic marker in CRC by examining its prognostic power in a different cohort – namely all patients undergoing surgery for CRC at the same institution from June 1998 to 2003.